Cargando…
Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
A vaccine against tuberculosis (TB), a disease resulting from infection with Mycobacterium tuberculosis (M.tb), is urgently needed to prevent more than a million deaths per year. Bacillus Calmette–Guérin (BCG) is the only available vaccine against TB but its efficacy varies throughout the world. Sub...
Autores principales: | Pinpathomrat, Nawamin, Bull, Naomi, Pasricha, Janet, Harrington-Kandt, Rachel, McShane, Helen, Stylianou, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903242/ https://www.ncbi.nlm.nih.gov/pubmed/33549390 http://dx.doi.org/10.1016/j.vaccine.2021.01.034 |
Ejemplares similares
-
Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model
por: Harrington-Kandt, Rachel, et al.
Publicado: (2018) -
Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine
por: Stylianou, Elena, et al.
Publicado: (2018) -
A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
por: Stylianou, Elena, et al.
Publicado: (2023) -
Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1(+) KLRG1(−) CD4(+) T cells
por: Bull, N. C., et al.
Publicado: (2018) -
Identification of antigens presented by MHC for vaccines against tuberculosis
por: Bettencourt, Paulo, et al.
Publicado: (2020)